| ๐ Myasthenia Gravis |
Autoantibodies to post-synaptic ACh receptors โ โ transmission |
Fluctuating weakness, ptosis, diplopia, dysphagia, fatigability |
Anti-AChR antibodies, EMG, CT/MRI for thymoma |
| โก Guillain-Barrรฉ Syndrome |
Immune-mediated demyelination post-infection |
Ascending symmetrical weakness, areflexia, respiratory failure risk |
NCS, CSF (โ protein, normal WCC) |
| ๐ง Amyotrophic Lateral Sclerosis |
Degeneration of UMN & LMN |
Progressive weakness, wasting, fasciculations, spasticity, hyperreflexia |
EMG, NCS, MRI (exclude mimics) |
| ๐งฌ Muscular Dystrophies |
Inherited dystrophin defects |
Proximal weakness, pseudohypertrophy, progressive disability |
Genetic testing, muscle biopsy, โ CK |
| โ ๏ธ Botulism |
Toxin blocks presynaptic ACh release |
Descending paralysis, CN palsies, respiratory weakness |
Toxin assays, NCS, exposure history |
| ๐ฅ Polymyositis / Dermatomyositis |
Autoimmune inflammation & necrosis |
Proximal weakness, dysphagia; dermato = heliotrope rash, Gottronโs papules |
โ CK, muscle biopsy, autoantibodies |
| ๐ฏ Lambert-Eaton Syndrome |
Antibodies to presynaptic VGCC (often paraneoplastic) |
Proximal leg weakness, autonomic signs, improves with activity |
Anti-VGCC Abs, EMG, cancer screening |
| ๐ CIDP |
Chronic autoimmune demyelination |
Symmetrical weakness + sensory loss โฅ8 weeks |
NCS/EMG, CSF (โ protein) |